[Lymphocyte levels before treatment with subcutaneous interleukin-2 and during maintenance treatment in relation to the clinical efficacy in metastatic renal carcinoma].

Source:http://linkedlifedata.com/resource/pubmed/id/7787856

Download in:

View as

General Info

PMID
7787856